[av_section min_height=“ min_height_px=’500px‘ padding=’default‘ shadow=’no-border-styling‘ bottom_border=’no-border-styling‘ id=“ color=’main_color‘ custom_bg=“ src=’https://hanf.ag/wp-content/uploads/2016/10/Anwendungsgebiete_313419206.jpg‘ attachment=’257′ attachment_size=’full‘ attach=’scroll‘ position=’top center‘ repeat=’stretch‘ video=“ video_ratio=’16:9′ overlay_opacity=’0.5′ overlay_color=“ overlay_pattern=“ overlay_custom_pattern=“ custom_class=“]
[av_one_full first min_height=“ vertical_alignment=’av-align-top‘ space=“ margin=’0px‘ margin_sync=’true‘ padding=’0px,0px,30px,0px‘ border=“ border_color=“ radius=’0px‘ radius_sync=’true‘ background_color=“ src=“ attachment=“ attachment_size=“ background_position=’top left‘ background_repeat=’no-repeat‘ animation=“ custom_class=“]
[av_heading tag=’h1′ padding=’10‘ heading=’Application areas‘ color=“ style=’blockquote modern-quote‘ custom_font=“ size=“ subheading_active=“ subheading_size=’15‘ custom_class=’h1-anwendungsgebiete-en‘][/av_heading]
[/av_one_full][av_one_half first min_height=’av-equal-height-column‘ vertical_alignment=’av-align-top‘ space=’no_margin‘ margin=’0px‘ margin_sync=’true‘ padding=’15px‘ padding_sync=’true‘ border=“ border_color=“ radius=’0px‘ radius_sync=’true‘ background_color=’#ffffff‘ src=“ attachment=“ attachment_size=“ background_position=’top left‘ background_repeat=’no-repeat‘ animation=’bottom-to-top‘ custom_class=“]
[av_textblock size=“ font_color=“ color=“ custom_class=’justified-text‘]
According to information provided by Federal Government, the diagnoses underlying the exemptions are varied. The main group currently is pain patients (including painful spasticity in multiple sclerosis) with a proportion of approximately 62 percent (as of June 2016). The next largest group are ADHD patients with a share of approx. 12 percent, followed by patients with depression (approx. 6 percent), inappetence / cachexia (approx. 4.5 percent), Tourette syndrome (approx. 4 percent), enteropathy (approx. 4 percent), epilepsy (approx. 3.5 percent), other psychiatric diseases (approx. 3 percent.) and/or other neurological diseases (approx. 0.5 percent) and lung diseases (approx. 0.5 percent).
[/av_textblock]
[/av_one_half][av_one_half min_height=“ vertical_alignment=“ space=“ custom_margin=“ margin=’0px‘ padding=’0px‘ border=“ border_color=“ radius=’0px‘ background_color=“ src=“ background_position=’top left‘ background_repeat=’no-repeat‘ animation=“]
[/av_one_half][av_hr class=’invisible‘ height=’400′ shadow=’no-shadow‘ position=’center‘ custom_border=’av-border-thin‘ custom_width=’50px‘ custom_border_color=“ custom_margin_top=’30px‘ custom_margin_bottom=’30px‘ icon_select=’yes‘ custom_icon_color=“ icon=’ue808′ font=’entypo-fontello‘ custom_class=“]
[/av_section]